Regulatory Rapporteur

Regulatory Rapporteur is our peer-reviewed journal, published 11 times per year and sent free to TOPRA members. Our CPD supplement is published four times a year and distributed with Regulatory Rapporteur.

October 2020 issue

Free articles

To read the current issue of Regulatory Rapporteur in its entirety, plus receive access to every issue going to back to 2015, join TOPRA today.

JOIN NOW

October 2020 Issue Cover

Members-only articles

  • Feature: Current use of artificial intelligence in the MedTech industries
  • Article: Regulatory approval of medical device software and digital health devices
  • Article: Devices without a medical purpose: how do they fit into the MDR?
  • Article: An overview of advanced therapy regulation – part I: the EU
  • Interview: Lessons for a full lifecycle in pharma
  • Feature: Regulatory affairs strategic planning: how to do it well

Use the issue archive below to download the complete October 2020 issue as a PDF or to access individual articles or complete issues going back to 2015.

Note: to access members-only content, you must be logged in to the site with your TOPRA Member account.

Issue archive

Non-members may access select articles per issue. Join TOPRA to get full access to our journal and CPD content.

Search the archive (TOPRA Membership required for full archive access)

Archived issues earlier than 2015

If you require Regulatory Rapporteur articles or back issues published prior to 2015, please email publications@topra.org.

Articles for purchase

For information about purchasing journals, articles or reprint licences, contact us at publications@topra.org

Write an article
Want to write for Regulatory Rapporteur?  Read our Regulatory Rapporteur Author Guidelines

 

Data pager
Data pager
 Page 1 of 4, items 1 to 20 of 64.
Show all 64
Latest Issues
Data pager
Data pager
 Page 1 of 4, items 1 to 20 of 64.
Show all 64
Volume: 17
Issue: 10

In This Issue:
Focus: Medical technologies
Plus:
• CPD - Insights on expedited drug development pathways
• ATMPs - An overview of advanced therapy regulation in the EU
• Strategic planning - How to do regulatory affairs strategic planning well
Volume: 17
Issue: 09

In This Issue:
Focus: Patient-focused development

Plus:
• Early access schemes: A heterogenous landscape with room for harmonisation
• ICH Q3E: Virtual symposium on extractables and leachables
• Patient information leaflets: Conveying complex information to patients
Volume: 17
Issue: 07

In This Issue:
Focus: Looking after special populations

Plus:
• Virtual clinical trials: Ensuring continuity of research during a pandemic
• ICH Q12: Benefits and challenges with this enhanced framework
• Veterinary medicine: CMDv pilot part II harmonisation project
Volume: 17
Issue: 06

In This Issue:
FOCUS: Biotechnology - Why and how regulators should keep pace with innovative biopharmaceutical advances

PLUS:
• Letter: A ‘SMArt’ new initiative for veterinary legislation
• Medical devices: Germany’s new device law, the EU MDR and COVID-19
• E-cigarettes: A look at the regulatory landscape in the US
Volume: 17
Issue: 05

In This Issue:
FOCUS: Healthcare regulatory affairs in China

PLUS:
• Letters: Regulators united in fight against COVID-19
• Meeting report: Drug repurposing for rare diseases
• Devices: Latest medical device standards update
Volume: 17
Issue: 04

In This Issue:
FOCUS: Real-world data - gathering data beyond clinical trials to obtain real-world evidence.

PLUS:
• Veterinary clinical trials: Overview and comparison between the EU and US
• Health apps: International initiatives to define requirements
• Mergers and acquisitions: Examining the benefits and challenges
Volume: 17
Issue: 03

In This Issue:
FOCUS: Career and professional development strategies - Learn how to develop your skills and advance your career

PLUS:
• Meeting report: Drug-device combination
products workshop
• Interview: Animal and plant health scientific advice
• Artificial Intelligence: Potential impact on medical technology roles
Volume: 17
Issue: 02

In This Issue:
FOCUS: New approaches to medicines - utilising technology to develop innovative medicinal therapies

PLUS:
• How to get ahead in the devices job market
• New intelligence in regulatory operations
• India's engagement at the international level
Volume: 17
Issue: 01

In This Issue:
FOCUS: Repurposing drugs to target unmet needs

PLUS:
• Regulatory landscape: Looking ahead at what's in store for 2020
• CMC - Accelerated development: trials and tribulations
• Veterinary medicines - The international regulation of animal health products
Volume: 16
Issue: 12

In This Issue:
FOCUS: TOPRA Symposium 2019 - Europe at the forefront of healthcare regulation
Volume: 16
Issue: 11

In This Issue:
FOCUS: North America - A look at recent developments in the regulatory landscape across the region

PLUS
• Orphan drugs: The practicalities of using the EMA’s IRIS platform
• Medical devices: New device standards from the US FDA consensus list
• Letters: Nonclinical requirements for biotech-derived drugs
Volume: 16
Issue: 10

In This Issue:
FOCUS: Falsified Medicines Directive

PLUS
• Latin America - Positive changes in the regulatory environment
• CPD - European medical devices legislative framework
• Virtual trials - Understanding the basics and exploring the benefits
Volume: 09
Issue: 09

In This Issue:
FOCUS: Ireland's regulatory framework

PLUS
• Interview: David Mukanga from the Gates Foundation, Africa
• Profile: FDA's Ned Sharpless
Volume: 16
Issue: 07

In This Issue:
FOCUS
Paediatric Medicines: How to address unmet needs in this vulnerable patient population

PLUS
• Drug-device combinations: major changes head
• DIA Europe 2019 - key topics for the future
• New EU VMR - impact on veterinary medicines
Volume: 16
Issue: 06

In This Issue:

FOCUS: Clinical trials

PLUS
• Malta's mutually beneficial interactions with EU partners
• Updates from the VMD for the veterinary sector
• Cultural diversity - tackling subliminal workplace bias
Volume: 16
Issue: 05

In This Issue:


FOCUS: EU Device and IVD Legislation

PLUS
• Producing periodic benefit–risk evaluation reports
• New FDA strategy for interaction with biosimilars sponsors
• Medicines development in Turkey: a regulator’s view
Volume: 16
Issue: 04

In This Issue:


FOCUS: Exploring New Health Technologies

PLUS
• How the European Commission supports HTA collaboration
• Insights on the unique regulatory requirements for GMOs
Volume: 16
Issue: 03

In This Issue:


FOCUS: Antimicrobial resistance: What the profession is doing to combat one of the greatest health threats today

PLUS
• The impact of the EU MDR on combination products
• Small markets - challenges for the regulator
• How to frame an EU-compliant pharmacovigilance system
Volume: 16
Issue: 02

In This Issue:


FOCUS: ATMPs

PLUS
• CMC section of an EU IMPD - advice for US sponsors
Volume: 16
Issue: 01

In This Issue:


FOCUS: Challenging access markets

PLUS
• EMA's relocation to the Netherlands
• Brexit's impact on the devices sector

No content found